Johnson & Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief Scientific Officer at J&J, the company “is increasing its manufacturing and preparing for clinical trials in September.” The clinical trials should provide sufficient data to facilitate development of the vaccines […]
NYSE:JNJJ
Recent Stories
Pot Stocks for the Next Wave (GTBIF, TLRY, NUGS, ACRGF, TCNNF)
Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul
Gearing Up for the Pot Stock Election Run (MJNA, CRLBF, MCTC, CURLF)
Alphabet Inc. Google Class A (NASDAQ: GOOGL) Is Considering an Investment in Vodafone Idea Ltd (NSE: IDEA) Struggling India Business
Walmart Inc (NYSE:WMT) Ventures Into Clothing Resale Market Through Partnership With ThreadUP